Press Releases 2021PDF DOWNLOAD VIEW ALL NEWS
Leveljump Announces Quotation on Frankfurt Stock Exchange
Toronto, ON – March, 22nd 2021 – LevelJump Healthcare Corp. (TSXV: JUMP) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that the Company’s are now quoted on the Frankfurt Stock Exchange ("FSE") under the symbol 75J.
The European listing is a very strategic move for the Company as the Frankfurt Stock Exchange is one of the world's largest trading centers for securities. With a share in turnover of around 90 per cent, it is the largest of Germany's stock exchanges. This is also reflected in the structure of its participants, of which almost half are from European countries outside of Germany.
The Company is excited to be able to offer increasing liquidity options for its shareholders through additional quotation mediums in Europe. Additional information about the Company can be found by visiting the Company’s SEDAR profile at www.sedar.com.
About LevelJump Healthcare
Leveljump Healthcare Corp., (TSXV: JUMP) is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler, Chief Executive Officer
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.